Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 447 of 5804
-
Engineered t cells take on ovarian cancer in new trial
Disease control Recruiting nowThe primary objectives are to evaluate the safety and efficacy of infusion of autologous ovarian cancer immunogene-modified T cells (OC-IgT cells).
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Could a diabetes drug help teens with rare obesity syndromes shed pounds?
Disease control Recruiting nowThis research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. …
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated Jun 26, 2026 17:35 UTC
-
New combo therapy aims to shrink breast tumors before surgery
Disease control ENROLLING_BY_INVITATIONThis is a prospective, single-center, randomize-controlled study. The purpose of this study is to evaluate the efficacy of neoadjuvant CDK4/6 inhibitors in patients with high-risk EPclin multigene risk analysis and non-response to Ki-67 2W, and to explore predictive biomarkers fo…
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Game on for life: app fights suicide in mental health patients
Disease control Recruiting nowPatients with mental disorders are at significantly higher risk of suicide after discharge compared to the general population and patients with other diseases. Currently, there is a lack of post-discharge community suicide risk management services in China. The research team's pr…
Phase: NA • Sponsor: Shenzhen Kangning Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo offers hope for advanced gallbladder cancer patients
Disease control ENROLLING_BY_INVITATIONThis is a single-arm, multicenter, Phase II clinical trial evaluating the efficacy and safety of Gemcitabine plus Nab-Paclitaxel (AG regimen) in combination with Iparomlimab and Tuvorilimab (a dual anti-PD-1/CTLA-4 bispecific antibody) in patients with advanced unresectable gallb…
Phase: PHASE2 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Nutrient sachets may boost vaccination rates in rural africa
Prevention Recruiting nowMalnutrition and infectious disease form a vicious circle, posing a double threat to vulnerable children in low- and middle-income countries. Malnutrition makes children more vulnerable to infectious diseases, while infectious diseases increase the risk of malnutrition. When caug…
Phase: NA • Sponsor: Alliance for International Medical Action • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
Personalized treatment for early water breaking could extend pregnancy safely
Disease control Recruiting nowThe goal of this clinical trial is to learn whether tailoring antibiotic and steroid treatment based on a lab result (interleukin-6, or IL-6) from amniotic fluid can help safely prolong pregnancy in people with preterm premature rupture of membranes (pPROM). This condition means …
Phase: PHASE3 • Sponsor: The Central and Eastern European Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study evaluates hypofractionated radiotherapy combined with PD-1 inhibitor-based systemic therapy in patients with metastatic solid tumors. Eligible patients will be enrolled into three cohorts according to tumor type: metastatic hepatocellular carcinoma, metastatic renal ce…
Phase: NA • Sponsor: Zhen Zhang • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Antifungal drug could boost immunotherapy for tough breast cancer
Disease control Recruiting nowTriple-negative breast cancer (TNBC) is as sociated with shorter overall survival than other breast cancer subtypes, despite the use of curative-intent anthracycline- and taxane-based systemic chemotherapy. Neoadjuvant therapy is now also recognized as the standard treatment for …
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Robotic glove may help stroke survivors regain hand control
Disease control CompletedStroke is a neurological deficit attributed to an acute focal injury of the central nervous system. A key component of stroke rehabilitation is improving upper limb function to reduce impairments and disabilities. A task-specific approach retraining for upper extremity control se…
Phase: NA • Sponsor: Adly A Adam • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could CAR t-cells tame myasthenia gravis? early trial launches
Disease control Recruiting nowA Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG). Anitocabtagene autoleucel (anito-cel) is a BCMA-directed CAR-T cell therapy.
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New study tracks how well alectinib keeps lung cancer from returning after surgery
Disease control Recruiting nowThis study is a multicenter, prospective, cohort study designed to evaluate the clinical outcomes and characteristics of resected stage II-IIIB anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) adult patients treated with Alectinib as adjuvant therapy i…
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New daily pill aims to lower blood pressure and weight in one go
Disease control OngoingGZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill could lower blood pressure and weight at the same time
Disease control OngoingGZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to shrink tough lung tumors
Disease control Recruiting nowThe aim of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of ES102 in combination with Toripalimab in subjects with advanced non-small cell lung cancer (NSCLC).
Phase: PHASE2 • Sponsor: Elpiscience (Suzhou) Biopharma, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New daily pill could help control blood pressure in overweight individuals
Disease control OngoingThe GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforglipron for the treatment of hypertension in participants with obesity or overwei…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to fight tough bile duct cancer
Disease control Recruiting nowThere're 2 parts in this interventional study: 1. The goal of phase Ib trial is to evaluate the safety and tolerability of AK130 in combination with AK112 therapy for the purpose of observing the incidence of dose limit toxicity (DLT) as well as the confirmation of maximum toler…
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New dye test could save testicles and spare thousands of boys from needless surgery
Diagnosis Recruiting nowTesticular torsion is a time critical condition for children and young people (CYP). It is difficult to diagnose without an operation. Missing it means the child will lose a testicle. There are no good diagnostic tests, only tests that delay the child's journey to theatre, which …
Phase: PHASE4 • Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New targeted pill aims to shrink lung tumors in patients with common gene mutation
Disease control OngoingTo evaluate the safety, tolerability, and preliminary efficacy of JS111 capsules in patients with locally advanced, metastatic, or recurrent NSCLC harboring EGFR mutations;to determine the recommended Phase II dose (RP2D).
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Antibody-Drug combo takes on Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis is a Phase Ib/II study to evaluate the safety, tolerability and efficacy of IBI343 in combination with chemotherapy in patients with advanced pancreatic cancer, including a Phase Ib safety introduction and Phase II expansion phase. In phase Ib (safe introduction phase), par…
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC